中国科技核心期刊
CN:31-1600/Q
ISSN:1004-0374
“健康与疾病的免疫”国际学术研讨会通知      关于有网站冒充本刊网站的声明
《生命科学》 2016, 28(9): 1075-1082
缺氧诱导因子-1α参与癌细胞迁移和侵袭的作用机理
蒋 珺1, 康晓曦1,罗 成2,王立魁3*,张 燕1*
(1 解放军452医院干部空勤科,成都 610000;2 爱沙尼亚塔土尔大学生物技术系;3 中国科学院微生物研究所病原微生物与免疫学重点实验室,北京 100101)
摘 要:在实体瘤中,无论是良性肿瘤,还是恶性肿瘤,低氧都是一种普遍现象,并且绝大多数肿瘤中存在低氧微环境。低氧与肿瘤的恶性进展、放射与化疗的耐受性和不良的预后有着密切的联系。缺氧诱导因子1(hypoxia inducible factor-1, HIF-1) 广泛存在于大多数肿瘤组织中,并且HIF-1 是一种存在于低氧条件下的转录因子。它是由氧调控表达的HIF-1α 亚基与组成型表达的HIF-1β 亚基组成的异二聚体。在常氧环境下,通过激活泛素蛋白酶体及氧依赖性降解区域的脯氨酸羟化而使HIF-1α 迅速降解,半衰期约为5 min,而在低氧状态下,HIF-1α 与β 亚基二聚化并稳定存在。二聚化的HIF-1 能够促进癌细胞的增殖、迁移以及侵袭。因此,HIF-1α 有可能成为抑制癌细胞生长迁移与侵袭的靶点,这将为化疗及高压氧治疗提供新的思路。综述近年国内外抗氧化环境下HIF-1 基因所主导的与癌细胞迁移和侵袭及其抑制相关的分子机理的研究,以便通过在抗炎、抗氧化条件下的增氧作用机理改进化疗效果。
 
The molecular mechanisms of hypoxia inducible factor(HIF)-1α in the migration and invasion of cancer cells
JIANG Jun1, KANG Xiao-Xi1, LUO Cheng2, WANG Li-Kui3*, ZHANG Yan1*
(1 Department of Geriatrics, The 452nd Hospital of PLA, Chengdu 610000, China; 2 Department of Biotechnology, University of Tartu, Estonia; 3 CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China)
Abstract: In a solid tumor, whether benign or malignant, hypoxia is a very common phenomenon, which affects the radiation and chemotherapies. Hypoxia-inducible factor (HIF)-1 as a transcription factor has been found in the majority of tumor tissues. HIF-1 is a heterodimer made of the subunit HIF-1α regulated by oxygen and the HIF-1β subunit with constitutive expression. Under normoxic environment, through the activation of the ubiquitin - oxygendependent degradation domain (ODDD), the HIF-1α is rapidly degraded through proline hydroxylation in the proteasome pathway, the half-life of HIF-1α is about 5 min. Under hypoxic conditions, HIF-1α can be stabilized by functional dimerization together with β subunit, which accelerates cell proliferation, migration and invasion in different kinds of cancers, thus HIF-1α is becoming one of the important inhibition targets for chemotherapies. This article reviews recent development of HIF-1 gene’s molecular action mechanism that are related to cancer cell migration and invasion as well as the inhibition target for chemotherapy and to improve the medication through hyperbaric oxygen together with the antioxidation and anti-inflammation.
 
首页 | 刊物简介 | 编委会 | 投稿须知 | 广告业务 | 过刊浏览 | 联系我们
中国科学院上海生命科学信息中心《生命科学》编辑部
Copyright © 2012-2015 《生命科学》编辑部 All Rights Reserved.
沪ICP备05033115号-30
您是第2877716 位访问者,欢迎!